Suchergebnisse
Suchergebnisse:
Daphne Koller (Hebrew: דפנה קולר; born August 27, 1968) is an Israeli-American computer scientist. She was a professor in the department of computer science at Stanford University and a MacArthur Foundation fellowship recipient. She is one of the founders of Coursera, an online education platform.
Daphne Koller (* 27. August 1968 in Jerusalem) ist eine israelische Informatikerin und Mitgründerin des Online-Unternehmens Coursera . Inhaltsverzeichnis. 1 Leben und Wirken. 2 Ehrungen und Mitgliedschaften. 3 Schriften (Auswahl) 4 Weblinks. 5 Einzelnachweise. Leben und Wirken.
- 27. August 1968
- israelische Informatikerin
- Jerusalem
- Koller, Daphne
Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients. She was the co-founder, co-CEO, and president of online education platform Coursera, the largest platform for massive open online courses (MOOCs), which has reached ...
Professor Daphne Koller Contact Information: home | biography | research | papers | my group courses | professional activities | FAQ | personal
Support vector machine active learning with applications to text classification. S Tong, D Koller. Journal of machine learning research 2 (Nov), 45-66. , 2001. 3796. 2001. A gene-coexpression network for global discovery of conserved genetic modules. JM Stuart, E Segal, D Koller, SK Kim. science 302 (5643), 249-255.
25. Okt. 2023 · Daphne Koller, AI pioneer and CEO of Insitro, explains how generative AI can create deep fakes of tissue images and reveal novel drug targets for cancer. She also discusses the merging of AI and biology, and the potential of digital biology for human health and the environment.
16. Nov. 2022 · Daphne Koller, founder and CEO of insitro, a company that uses AI to create better medicines, shares her vision and insights on how machine learning can transform drug discovery. Learn how insitro collects and analyzes data, identifies disease patterns, and tests therapeutic interventions with ML.
